Resignation of Non-Executive Director
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, announces the resignation of Nicholas (Nick) Ingrassia as a Non-Executive Director with immediate effect to focus on his other business commitments.Nick has sat on the Board of Apollon since it went public on the Aquis Growth market in April 2021. Nick Ingrassia, of Apollon Formularies, commented “It has been an honour and a pleasure to serve on the Apollon board alongside a group of such brilliant and dedicated directors. I